REGENXBIO Inc. RGNX

7.40 0.16 2.21% as of 25 Sep
Market cap
$487.8M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
230.07 234.69 275.26 364.64 457.44 475.74 296.21 319.76 160.78 89.55
Receivables
26.38 20.47 24.79 28.08 32.44 43.00 38.15 8.59 0.47 1.03
Other current assets
12.91 13.77 20.40 9.35 10.20 1.95 4.20 3.83 1.41 1.01
Total current assets
281.28 278.00 334.97 415.98 518.83 531.20 345.03 337.91 168.00 93.37
Property, Plant, Equpment (Net)
104.86 117.59 132.10 141.69 131.55 56.47 28.97 28.70 13.98 9.32
Long-Term Investments
10.79 10.18 38.87 200.56 391.91 46.81 103.79 150.82 15.62 69.41
Long-term receivables
2.31 0.47 0.70 1.50 2.26 3.27 4.16 23.01 0.00 —
Long-term assets (Other)
6.64 6.03 6.84 8.43 8.46 6.61 5.89 3.37 1.09 0.63
Total non-current assets
171.75 187.99 239.00 417.29 595.08 176.97 152.88 205.90 30.68 79.36
Total Assets
453.03 465.99 573.97 833.27 1,113.90 708.16 497.91 543.81 198.68 172.73
Accounts Payable
21.36 22.80 22.79 27.21 11.39 10.62 6.41 4.41 4.83 1.54
Accrued Expenses
38.39 38.07 49.70 46.79 76.11 49.08 24.85 17.16 9.61 8.13
Current Revenue (Deferred)
10.45 0.12 0.15 1.83 3.33 0.45 — 0.60 0.00 —
Other current liabilities
39.61 34.31 50.57 48.60 37.89 18.79 25.00 17.00 10.00 8.13
Total current liabilities
118.10 103.19 130.27 130.43 130.47 81.45 33.68 22.18 14.44 9.67
Long Term Debt (Total)
— — — 89.00 85.00 70.00 9.00 5.85 — —
Non-current Revenue (Deferred)
18.94 — — — — 3.78 3.33 4.43 1.21 1.33
Non-current Liabilities (Other)
148.05 29.01 49.73 97.84 134.21 175.03 1.83 2.51 1.00 1.33
Total non-current liabilities
232.20 103.14 131.96 186.64 219.13 248.96 14.04 12.79 1.21 1.33
Total liabilities
350.30 206.34 262.23 317.07 349.61 330.41 47.71 34.97 15.65 11.00
Additional Paid In Capital
1,229.44 1,192.54 1,021.21 973.15 928.10 667.18 627.81 592.58 371.50 276.35
Common Stock (Net)
0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Retained Earnings
(1,126.03) (932.15) (705.05) (441.55) (161.23) (289.07) (177.82) (83.02) (187.76) (114.59)
Common Equity (Total)
102.73 259.65 311.74 516.20 764.30 377.75 450.20 508.85 183.03 161.74
Shareholders Equity (Total)
102.73 259.65 311.74 516.20 764.30 377.75 450.20 508.85 183.03 161.74
Shareholders Equity and Liabilities (Total)
453.03 465.99 573.97 833.27 1,113.90 708.16 497.91 543.81 198.68 172.73
Shares (Common)
50.89 49.55 44.05 43.30 42.83 37.48 36.99 36.12 31.30 26.48
Shareholders Equity (Tangible)
102.73 259.65 311.74 516.20 764.30 377.75 450.20 508.85 183.03 161.74
Net Debt
(230.07) (234.69) (275.26) (275.64) (372.44) (405.74) (287.21) (313.91) (160.78) (89.55)
Total Debt
— — — 89.00 85.00 70.00 9.00 5.85 — —

Fold the line items

In millions of $ except per-share values · columns are period end dates